Risk Factors of Colorectal Stricture Associated with Developing High-Grade Dysplasia or Cancer in Ulcerative Colitis: A Multicenter Long-term Follow-up Study

키워드

참고문헌 (37)

1. Kaplan GG, "Understanding and preventing the global increase of inflammatory bowel disease", Gastroenterology, 152, pp.313~321 (2017)
2. Melmed GY, "Future biologic targets for IBD : potentials and pitfalls", Nat Rev Gastroenterol Hepatol, 7, pp.110~117 (2010)
3. Marchioni Beery R, "Current approaches to the management of new-onset ulcerative colitis", Clin Exp Gastroenterol, 7, pp.111~132 (2014)
4. Ording AG, "Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease : a nationwide population-based cohort study", Inflamm Bowel Dis, 19, pp.800~805 (2013)
5. Ekbom A, "Ulcerative colitis and colorectal cancer : a population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
6. Jess T, "Risk of colorectal cancer in patients with ulcerative colitis : a meta-analysis of populationbased cohort studies", Clin Gastroenterol Hepatol, 10, pp.639~645 (2012)
7. Derikx LA, "Risk of neoplasia after colectomy in patients with inflammatory bowel disease : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 14, pp.798~806 (2016)
8. Eaden JA, "The risk of colorectal cancer in ulcerative colitis : a meta-analysis", Gut, 48, pp.526~535 (2001)
9. Yamagata M, "Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis", Digestion, 84, pp.12~21 (2011)
10. Edwards FC, "The course and prognosis of ulcerative colitis : III. complications", Gut, 5, pp.1~22 (1964)
11. De Dombal FT, "Local complications of ulcerative colitis : stricture, pseudopolyposis, and carcinoma of colon and rectum", Br Med J, 1, pp.1442~1447 (1966)
12. Gumaste V, "Benign and malignant colorectal strictures in ulcerative colitis", Gut, 33, pp.938~941 (1992)
13. Fumery M, "Detection of dysplasia or cancer in 3. 5% of patients with inflammatory bowel disease and colonic strictures", Clin Gastroenterol Hepatol, 13, pp.1770~1775 (2015)
14. Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19(Suppl A), pp.5A~36A (2005)
15. 이혜원, "Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease", Gut and Liver, 12(5), pp.530~536 (2018), 거트앤리버 소화기연관학회협의회
16. Xu W, "Long-term quality of life associated with early surgical complications in patients with ulcerative colitis after ileal pouch-anal anastomosis : a single-center retrospective study", Int J Surg, 48, pp.174~179 (2017)
17. Lashner BA, "Dysplasia and cancer complicating strictures in ulcerative colitis", Dig Dis Sci, 35, pp.349~352 (1990)
18. Hunt RH, "Colonoscopy in management of colonic strictures", Br Med J, 3, pp.360~361 (1975)
19. Itzkowitz SH, "Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease : the role of inflammation", Am J Physiol Gastrointest Liver Physiol, 287, pp.G7~G17 (2004)
20. Winawer S, "Colorectal cancer screening and surveillance : clinical guidelines and rationale-update based on new evidence", Gastroenterology, 124, pp.544~560 (2003)
21. Eaden JA, "Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease", Gut, 51(Suppl 5), pp.V10~V12 (2002)
22. Lutgens MW, "High frequency of early colorectal cancer in inflammatory bowel disease", Gut, 57, pp.1246~1251 (2008)
23. Rutter MD, "Cancer surveillance in longstanding ulcerative colitis : endoscopic appearances help predict cancer risk", Gut, 53, pp.1813~1816 (2004)
24. Filmann N, "Prevalence of anemia in inflammatory bowel diseases in European countries : a systematic review and individual patient data meta-analysis", Inflamm Bowel Dis, 20, pp.936~945 (2014)
25. Vegh Z, "Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease", Scand J Gastroenterol, 51, pp.848~854 (2016)
26. Madanchi M, "The relevance of vitamin and iron deficiency in patients with inflammatory bowel diseases in patients of the Swiss IBD Cohort", Inflamm Bowel Dis, 24, pp.1768~1779 (2018)
27. Bergamaschi G, "Prevalence and pathogenesis of anemia in inflammatory bowel disease : influence of anti-tumor necrosis factor-alpha treatment", Haematologica, 95, pp.199~205 (2010)
28. Wiesner RH, "Clinicopathologic features of the syndrome of primary sclerosing cholangitis", Gastroenterology, 79, pp.200~206 (1980)
29. Rosen CB, "Cholangiocarcinoma complicating primary sclerosing cholangitis", Semin Liver Dis, 11, pp.26~30 (1991)
30. Shetty K, "The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis", Am J Gastroenterol, 94, pp.1643~1649 (1999)
31. Braden B, "Risk for colorectal neoplasia in patients with colonic Crohn’s disease and concomitant primary sclerosing cholangitis", Clin Gastroenterol Hepatol, 10, pp.303~308 (2012)
32. Navaneethan U, "Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn’s colitis", Gastroenterol Rep(Oxf), 4, pp.226~231 (2016)
33. Lampinen M, "High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis", J Crohns Colitis, 13, pp.341~350 (2019)
34. Donaldson CW, "Increased local cytokine production at culprit superficial femoral artery plaques", J Thromb Thrombolysis, 36, pp.293~299 (2013)
35. Antoniades C, "The CD40", CD40 ligand system : linking inflammation with atherothrombosis, 2009, pp.54, 669~677
36. Haller ST, "Mechanisms and treatments for renal artery stenosis", Discov Med, 16, pp.255~260 (2013)
37. Friedrich K, "CD14 is associated with biliary stricture formation", Hepatology, 64, pp.843~852 (2016)

관련 논문AI추천